Webcasting The New Norm During COVID-19 As FDA Reschedules Opthalmic AdComm Panel
Executive Summary
In a sign of the times, regulators are holding an advisory committee meeting for an ophthalmic device online because of the pandemic.
You may also be interested in...
FDA Makes 2nd Attempt At Virtual MDUFA Public Meeting
For the second time in the past few months the US agency has rescheduled a webcast of a public meeting meant to start MDUFA V user-fee negotiations.
FDA To Virtually Convene Orthopedic Panel
In a sign the US FDA is trying to address key issues not related to COVID-19, the agency is bringing together an expert panel almost five months after it was originally slated to meet to discuss classifying a slew of orthopedic devices.
No End In Sight: FDA Postpones Another In-Person Meeting Due To COVID-19
The US agency had planned to hold an in-person meeting of its ophthalmic advisory committee in early June, indicating hope that things would be back to some form of normal by then. But due to the ongoing coronavirus pandemic, it has postponed that meeting until further notice.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: